Clearside Biomedical
2,333
$1.689876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$1.68
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.04 (-2.33%) Today
-$0.00 (-0.01%) As of 7:53 AM EDT after-hours
Why Robinhood?
You can buy or sell CLSD and other stocks, options, ETFs, and crypto commission-free!
About CLSD
Clearside Biomedical, Inc. Common Stock, also called Clearside Biomedical, is a clinical stage biopharmaceutical company, which engages in the development of drug therapies to treat blinding diseases of the eye. Read More Its pipeline includes Suprachoroidal CLS-TA, Suprachoroidal, Suprachoroidal CLS-TA, and gene therapy. The company was founded by Samir Kumar Patel, Vladimir Zarnitsyn, Mark Prausnitz, Daniel H. White, and Henry F. Edelhauser in May 2011 and is headquartered in Alpharetta, GA.
Employees
33
Headquarters
Alpharetta, Georgia
Founded
2011
Market Cap
75.38M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
286.99K
High Today
$1.74
Low Today
$1.65
Open Price
$1.74
Volume
164.97K
52 Week High
$4.13
52 Week Low
$0.56
Collections
Analyst Ratings
50%
of 6 ratings
Buy
50%
Hold
50%
Sell
0%
CLSD Earnings
-$0.68
-$0.45
-$0.23
$0.00
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Estimated
— per share
Actual
Expected Aug 5